ALKS
Alkermes Inc. plc
stockNASDAQ
Market OpenOct 5, 2026 3:08:22 PM EDT
43.13USD+3.305%(+1.38)1,352,362
43.11Bid48.82Ask5.71SpreadPre-marketOct 5, 2026 9:26:30 AM EDT
41.50USD-0.599%(-0.25)
ALKS News
Stifel reiterates Alkermes stock rating on pipeline confidence · 
Investing.com
Alkermes reports positive top-line Phase Ib trial data for ALKS 7290 · 
Clinical Trials Arena
TD Cowen reiterates Alkermes stock Buy rating on ADHD trial data · Investing.com
How Alkermes Used Its Narcolepsy Playbook In ADHD — And Seemingly Won · 
Investor's Business Daily
Stifel reiterates Alkermes stock rating on ADHD drug trial data · Investing.com
Alkermes rises on phase 1 results for ADHD drug ALKS 7290 · 
Seeking Alpha
Why is Alkermes stock surging today? · Investing.com
Alkermes stock jumps on positive ADHD drug trial results · Investing.com
Alkermes reports positive phase 1 data for ADHD drug candidate · Investing.com
Alkermes slides 7%, reaching multi-month low · Seeking Alpha
Alkermes appoints Anne Whitaker to board of directors · Investing.com